Shortage of HYDROXO-B12 hydroxocobalamin chloride 1mg/1mL injection ampoule (AUST R: 161606)
Updated: Aug 28
Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position.
For current Australian shortage and supply information, see medicine shortages in Australia.
Dear Healthcare Professional,
Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of HYDROXO-B12 hydroxocobalamin chloride 1mg/1mL injection ampoule (AUST R: 161606) in Australia.
The Australian registered medicine, HYDROXO-B12 hydroxocobalamin chloride 1mg/1mL injection ampoule (AUST R: 161606) Active ingredients: hydroxocobalamin chloride Dosage form: Injection, Solution Sponsor: Aspen Pharmacare Australia Pty Ltd is currently in shortage due to manufacturing issues.
Pro Pharmaceuticals Group has arranged for the supply of an alternative product,NEO-CYTAMEN hydroxocobalamin 1000 micrograms/mL solution for injection (UK). This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 30th March 2024
Other brands of this product in Australia include NEO-B12 INJECTION Hydroxocobalamin 1000 microgram/1 mL injection ampoule, VITA-B12 INJECTION hydroxocobalamin acetate 1mg/ 1 mL solution for injection ampoule, HYDROXO-B12 hydroxocobalamin chloride 1mg/1mL injection ampoule
For orders, please email to orders@propg.com.au
